15:10 EDT Finch Therapeutics trading resumes
Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly
See the top stocks recommended by analysts >>
Read More on FNCH:
- Finch Announces Reverse Stock Split of Common Stock
- Finch Therapeutics Reports First Quarter 2023 Financial Results and Provides Business Updates
- Finch Therapeutics appoints Matthew Blischak CEO
- Finch enters CP101 clinical trial agreement with Brigham and Women’s Hospital
- Finch Therapeutics Announces Clinical Collaboration in Ulcerative Colitis with Brigham and Women’s Hospital and Updates to University of Minnesota License Agreement